COVID-19: Here’s the difference between vaccines, antibodies

Vaccines are chemicals that help the body develop antibodies while antibodies are developed by the body’s immune system to fight pathogens

Moderna’s COVID-19 breakthrough: Is the media hype justified

The biotech firm develops vaccine against novel coronavirus disease that shows positive results for eight patients

Early human trial of COVID-19 vaccine gives positive results

Developed by Beijing-based firm, the vaccine shows development of both forms of immunity  

Coronavirus update: ICMR sets Aug 15 date for COVID-19 vaccine launch

India’s COVID-19 vaccine: Study investigators say August 15 deadline unachievable

Indian Council of Medical research suggests a month’s time to complete three phases, global experiments taking months

No COVID-19 vaccine before 2021, Centre puts out then deletes

Sentence in question inadvertently included: PIB official; Things are contextual, says author of original article 

Simply put: Let’s plant a COVID-19 vaccine

No community transmission of COVID-19 in India, health ministry repeats

Silent on deadline for Indian COVID-19 vaccine; says human trials yet to take off  

COVID-19 airborne transmission possible in some indoor settings: WHO

Asymptomatic patients can pass on virus, extent unknown

Phase 1 human trials of Oxford University encouraging: Lancet

The sample size will have to be expanded across demography to check safety and efficacy  

COVID-19: Trump’s promise fuels anti-vaxx movement

Anti-vaccine theories inspire fear in the general population, undermining a coordinated effort to defeat the virus

Will there be a middle path for affordable COVID-19 vaccines?

It is expected for COVID-19 vaccines to be classified as 'global public goods', given their development is being substantially funded by …

Vaccine hesitancy on the rise across the globe, reveals cross-country survey

India bucks the trend; Afghanistan, Indonesia, Pakistan, the Philippines, South Korea major concerns

कोविड-19 वैक्सीन का सबसे बड़ा उत्पादक बन सकता है भारत: हॉटेज

ग्लोबल वैक्सीनेशन में भारत की भूमिका, इसकी चुनौतियां, वैक्सीन विरोधी अभियान और इस पर हो रही राजनीति पर हॉटेज ने डाउन टू अर्थ से ...

Simply put: The (side) effects of COVID-19 vaccine

कोरोना वैक्सीन अपडेट: कोविशील्ड के तीसरे चरण के चिकित्सीय परीक्षण के लिए पूरा हुआ नामांकन

भारत में विकसित किए जा रही वैक्सीन में, कोविशील्ड मानव परीक्षण के उन्नत चरण में है

Simply Put: Vaccine vs COVID-19

Why the Oxford AstraZeneca vaccine is now a global game changer

There were no cases of severe COVID-19 in those who received the vaccine. And it seems to generate a protective immune response in older people

Simply Put: COVID-19 vs climate change

Moderna claims 94% efficacy for its COVID-19 vaccine, to seek emergency nod

No Indian partner yet for production or distribution; results not final

कोरोना वैक्सीन अपडेट: सरकार ने कहा, स्वैच्छिक होगा वैक्सीन की डोज लेना

कोरोनावायरस वैक्सीन को लेकर अब तक क्या कुछ हो रहा है, पढ़ें आज का अपडेट-

36 प्रतिशत ग्रामीणों ने कहा, मुफ्त में लगाई जाए कोरोना वैक्सीन: सर्वे

ग्रामीण मीडिया प्लेटफॉर्म गांव कनेक्शन ने ग्रामीण क्षेत्रों में व्यापक सर्वेक्षण किया है

कितने महीने तक दोबारा कोरोना होने का आसार नहीं रहता?

शोधकर्ताओं ने कहा है कि जिन लोगों को एक बार कोविड-19 हो जाता है, उनमें कम से कम आठ महीनों तक फिर से संक्रमण ...

Serum Institute’s COVID-19 vaccine up for emergency approval

Civil society organisations urge Indian drug regulator to put vaccine trial data in public domain  

Norway reports deaths related to COVID-19 vaccination

Situation not alarming, only ‘small exception’ affected by Pfizer mRNA vaccine: Medical director of Norwegian Medicines Agency